# Lisdexamfetamine Dimesylate

NDC: 0054-0371
Generic name: lisdexamfetamine dimesylate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230825

FDA application: ANDA202827

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0371"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0371
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6740a621-9bec-4178-a4fc-a3fc89f34e0a